OLLERT Markus

University of Luxembourg

Main Referenced Co-authors

WILMES, Paul (10)

FAGHERAZZI, Guy (8)

Domingues, Olivia (7)

HE, Feng (7)

KRÜGER, Rejko (7)

Main Referenced Keywords

COVID-19 (10); Humans (10); SARS-CoV-2 (10); Animals (5); Female (4);

Main Referenced Unit & Research Centers

Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) (2)

Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) (2)

LIH - Luxembourg Institute of Health (1)

Luxembourg Centre for Systems Biomedicine (LCSB): Eco-Systems Biology (Wilmes Group) (1)

Main Referenced Disciplines

Immunology & infectious disease (8)

Life sciences: Multidisciplinary, general & others (4)

Neurology (3)

Oncology (3)

Biochemistry, biophysics & molecular biology (2)

Publications (total 23)

Search in publications

The most cited

138 citations (OpenAlex)

Wierz, M., Pierson, S., Guyonnet, L., VIRY, E., Lequeux, A., Oudin, A., NICLOU, S. P., OLLERT, M., BERCHEM, G. J. M. J., JANJI, B., Guérin, C., PAGGETTI, J., & MOUSSAY, E. (05 April 2018). Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood, 131 (14), 1617-1621. doi:10.1182/blood-2017-06-792267 https://hdl.handle.net/10993/60447